Did These Stocks Miss or Beat Analyst Expectations?

Shire PLC (NASDAQ:SHPG) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.35 in the quarter versus EPS of $ in the year-earlier quarter. Revenue Decreased 0.84% to $1.16 billion from the year-earlier quarter.

reported adjusted EPS income of $0.35 per share. By that measure, the company beat the mean analyst estimate of $0. It beat the average revenue estimate of $0.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

SHPG

MEDNAX, Inc. (NYSE:MD) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 12.24% to $1.1 in the quarter versus EPS of $0.98 in the year-earlier quarter. Revenue Rose 18.95% to $502.7 million from the year-earlier quarter.

MEDNAX, Inc. reported adjusted EPS income of $1.1 per share. By that measure, the company beat the mean analyst estimate of $1.09. It missed the average revenue estimate of $504.17 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MD

MWI Veterinary Supply, Inc. (NASDAQ:MWIV) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 14.42% to $1.19 in the quarter versus EPS of $1.04 in the year-earlier quarter. Revenue Rose 11.03% to $563.1 million from the year-earlier quarter.

MWI Veterinary Supply, Inc. reported adjusted EPS income of $1.19 per share. By that measure, the company beat the mean analyst estimate of $1.17. It missed the average revenue estimate of $571.07 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MWIV

Valeant Pharmaceuticals International (NYSE:VRX) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 124.14% to $1.30 in the quarter versus EPS of $0.58 in the year-earlier quarter. Revenue Rose 24.75% to $1.07 billion from the year-earlier quarter.

Valeant Pharmaceuticals International reported adjusted EPS income of $1.30 per share. By that measure, the company beat the mean analyst estimate of $1.25. It beat the average revenue estimate of $297.08 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

VRX

Actavis (NYSE:ACT) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 21.34% to $1.99 in the quarter versus EPS of $1.64 in the year-earlier quarter. Revenue Rose 24.35% to $1.9 billion from the year-earlier quarter.

Actavis reported adjusted EPS income of $1.99 per share. By that measure, the company beat the mean analyst estimate of $1.86. It missed the average revenue estimate of $1.97 billion.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ACT

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.